Growth Metrics

PROCEPT BioRobotics (PRCT) Cash from Investing Activities (2020 - 2025)

PROCEPT BioRobotics has reported Cash from Investing Activities over the past 6 years, most recently at -$1.8 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at -$1.8 million for Q4 2025, down 57.58% from a year ago — trailing twelve months through Dec 2025 was -$9.4 million (down 112.2% YoY), and the annual figure for FY2025 was -$9.4 million, down 112.2%.
  • Cash from Investing Activities for Q4 2025 was -$1.8 million at PROCEPT BioRobotics, up from -$2.9 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for PRCT hit a ceiling of -$39000.0 in Q1 2021 and a floor of -$8.7 million in Q4 2023.
  • Median Cash from Investing Activities over the past 5 years was -$1.3 million (2022), compared with a mean of -$2.1 million.
  • Biggest five-year swings in Cash from Investing Activities: crashed 9607.27% in 2023 and later skyrocketed 95.74% in 2024.
  • PROCEPT BioRobotics' Cash from Investing Activities stood at -$332000.0 in 2021, then plummeted by 160.84% to -$866000.0 in 2022, then crashed by 906.35% to -$8.7 million in 2023, then skyrocketed by 86.53% to -$1.2 million in 2024, then plummeted by 57.58% to -$1.8 million in 2025.
  • The last three reported values for Cash from Investing Activities were -$1.8 million (Q4 2025), -$2.9 million (Q3 2025), and -$2.8 million (Q2 2025) per Business Quant data.